Results 201 to 210 of about 35,531 (245)

Monoclonal Gammopathy of Multisystemic Significance: A Challenging Diagnosis of Light Chain Amyloidosis. [PDF]

Cureus
Owolabi O, Yera HO, Jenkins K, Pakala V, Kundu S.   +4 more
europepmc   +1 more source

A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils. [PDF]

Nat Commun
Martinez-Rivas G, Ayala MV, Bender S, Codo GR, Swiderska WK, Lampis A, Pedroza L, Merdanovic M, Sicard P, Pinault E, Richard L, Lavatelli F, Giorgetti S, Canetti D, Rinsant A, Kaaki S, Ory C, Oblet C, Pollet J, Naser E, Carpinteiro A, Roussel M, Javaugue V, Jaccard A, Bonaud A, Delpy L, Ehrmann M, Bridoux F, Sirac C.   +28 more
europepmc   +1 more source

Big data analytics & pathology services in NHS: achieving step changes in capacity [PDF]

, 2016
Douglas, S, Laffan, M, Littlewood, R
core  

Novel targeted therapies for immunoglobulin light chain amyloidosis: latest updates from the 2024 ASH annual meeting. [PDF]

J Hematol Oncol
Bu Q, Zhu HH, Chen W.
europepmc   +1 more source

Comprehensive prognosis assessment of cardiovascular magnetic resonance parametric mapping in light chain amyloidosis. [PDF]

J Cardiovasc Magn Reson
Li X, Guo Y, Shen K, Huang S, Gao Y, Lin L, Wang J, Cao J, Cao X, Jin Z, Zhang Z, Varga-Szemes A, Schoepf UJ, Li J, Wang Y.   +14 more
europepmc   +1 more source

Outcomes of BTD vs. BCD as initial treatment of renal amyloid light-chain amyloidosis: a retrospective cohort study in China. [PDF]

Ren Fail
Li S, He W, Yau HH, Xie J, Zhu Y, Chen X, Zhang S, Zhang Y, Liao P, Liu H, Li L, Zhong L, Wang W.   +12 more
europepmc   +1 more source

Loss of vision as the first manifestation of amyloid light-chain amyloidosis. [PDF]

EJHaem
van de Donk NWCJ, Huysentruyt C, Dhooge MRP.   +2 more
europepmc   +1 more source

Renal Involvement in Monoclonal Gammopathies [PDF]

, 2010
Carvalho, D, Carvalho, F, Ferreira, A, Ferreira, AC, Galvão, MJ, Nolasco, F, Santos, MC, Viana, H   +7 more
core  

Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis

Xiaozhe Li, Meilan Chen, Junru Liu, Jingli Gu, Beihui Huang, Lifen Kuang, Juan Li   +6 more
openalex   +1 more source

Treatment Approach for Advanced Systemic Light Chain Amyloidosis: A Case Report. [PDF]

Cureus
Hachem MAM, Nasreddine GM, Farhat S, Hammoud ZM, Saad F, Saad WA.   +5 more
europepmc   +1 more source